PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1600.0
(-1.23%)
IDR 1600.0
(-1.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1890.88 Billion | 1917.04 Billion | 1900.89 Billion | 1829.69 Billion | 1813.02 Billion | 1699.65 Billion |
| Cost of Revenue | 948.47 Billion | 910.91 Billion | 905.12 Billion | 897.71 Billion | 839.53 Billion | 774.24 Billion |
| Gross Profit | 942.41 Billion | 1006.12 Billion | 995.76 Billion | 931.98 Billion | 973.48 Billion | 925.4 Billion |
| Operating Expenses | 762.07 Billion | 1569.72 Billion | 805.78 Billion | 727.97 Billion | 680.05 Billion | 677.46 Billion |
| Selling, General and Administrative Expenses | 762.07 Billion | 482.09 Billion | 454.77 Billion | 393.34 Billion | 388.43 Billion | 397.61 Billion |
| Research and Development Expenses | - | 25.01 Billion | 40.3 Billion | 26.3 Billion | 23.66 Billion | 23.17 Billion |
| Other Expenses | - | 1062.61 Billion | 310.7 Billion | 308.33 Billion | 267.94 Billion | 11.14 Billion |
| Cost and Expenses | 1700.83 Billion | 2480.64 Billion | 1710.91 Billion | 1625.68 Billion | 1519.59 Billion | 1451.7 Billion |
| Operating Income | 190.05 Billion | 198.34 Billion | 208.6 Billion | 210.71 Billion | 296.62 Billion | 267.3 Billion |
| Interest Expense | 381.42 Million | 171.14 Million | 123.47 Million | 78.59 Million | 429.56 Million | 498.62 Million |
| Income Tax Expense | 45.3 Billion | 51.69 Billion | 65.06 Billion | 51.99 Billion | 79.46 Billion | 72.19 Billion |
| Earnings before Tax | 191.63 Billion | 201.07 Billion | 211.79 Billion | 214.06 Billion | 301.25 Billion | 272.84 Billion |
| Net Income | 146.33 Billion | 149.37 Billion | 146.5 Billion | 162.07 Billion | 221.78 Billion | 200.65 Billion |
| Earnings Per Share Basic | 130.66 | 133.37 | 130.81 | 144.71 | 198.24 | 179.80 |
| Earnings Per Share Diluted | 130.66 | 133.37 | 130.81 | 144.71 | 198.24 | 179.80 |
| Weighted Average Shares Outstanding | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.11 Billion | 1.11 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.11 Billion | 1.11 Billion |
| Gross Margin | 0.50 | 0.52 | 0.52 | 0.51 | 0.54 | 0.54 |
| EBIT Margin | 0.14 | 0.12 | 0.13 | 0.13 | 0.18 | 0.17 |
| Profit Margin | 0.08 | 0.08 | 0.08 | 0.09 | 0.12 | 0.12 |
| EBITDA | 255.91 Billion | 262.89 Billion | 272.74 Billion | 271.08 Billion | 352.98 Billion | 297.07 Billion |
| Earnings Before Tax Margin | 0.10 | 0.10 | 0.11 | 0.12 | 0.16 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 505.44 Billion | 554.92 Billion | 532.28 Billion | 1890.88 Billion | 541.36 Billion | 367.08 Billion |
| Cost of Revenue | 232.95 Billion | 274.21 Billion | 247.63 Billion | 948.47 Billion | 267.74 Billion | 186.91 Billion |
| Gross Profit | 272.49 Billion | 280.71 Billion | 284.64 Billion | 942.41 Billion | 273.61 Billion | 180.16 Billion |
| Operating Expenses | 234.46 Billion | 225.54 Billion | 197.36 Billion | 762.07 Billion | 190.83 Billion | 193.49 Billion |
| Selling, General and Administrative Expenses | 145.32 Billion | 128.94 Billion | 109.09 Billion | - | 190.83 Billion | 110.91 Billion |
| Research and Development Expenses | - | - | - | - | 10.35 Billion | 7.98 Billion |
| Other Expenses | 89.13 Billion | 6.04 Billion | 1.3 Billion | 12.28 Billion | -21.79 Billion | 13.94 Billion |
| Cost and Expenses | 467.41 Billion | 499.76 Billion | 445 Billion | 1710.55 Billion | 458.58 Billion | 380.41 Billion |
| Operating Income | 39.61 Billion | 64.19 Billion | 90.86 Billion | 180.33 Billion | 82.78 Billion | 4.14 Billion |
| Interest Expense | 12.3 Million | 13.38 Million | 14.45 Million | 68.28 Million | 15.51 Million | 16.55 Million |
| Income Tax Expense | 12.61 Billion | 13.11 Billion | 23.68 Billion | 45.3 Billion | 14.16 Billion | 1.11 Billion |
| Earnings before Tax | 40.64 Billion | 64.98 Billion | 91.17 Billion | 191.63 Billion | 60.68 Billion | 4.62 Billion |
| Net Income | 28.03 Billion | 51.86 Billion | 67.48 Billion | 146.33 Billion | 46.51 Billion | 3.5 Billion |
| Earnings Per Share Basic | 25.43 | 46.31 | 60.00 | - | 41.53 | 3.13 |
| Earnings Per Share Diluted | 25.43 | 46.31 | 60.00 | - | 41.53 | 3.13 |
| Weighted Average Shares Outstanding | 1.1 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.1 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion | 1.12 Billion |
| Gross Margin | 0.54 | 0.51 | 0.53 | 0.50 | 0.51 | 0.49 |
| EBIT Margin | 0.10 | 0.13 | 0.19 | - | 0.18 | 0.03 |
| Profit Margin | 0.06 | 0.09 | 0.13 | 0.08 | 0.09 | 0.01 |
| EBITDA | 49.93 Billion | 72.59 Billion | 99.44 Billion | - | 100.07 Billion | 12.32 Billion |
| Earnings Before Tax Margin | 0.08 | 0.12 | 0.17 | 0.10 | 0.15 | 0.01 |
SHREESHAY
RJDG
1980
FQT
603016
NETD